NCT02134067 2024-09-05Dose-escalating, Safety, Tolerability and PK Study of TAS-119 in Combination With Paclitaxel in Patients With Advanced Solid TumorsTaiho Oncology, Inc.Phase 1 Terminated30 enrolled
NCT02448589 2024-09-04An Investigation of TAS-119 MonotherapyTaiho Oncology, Inc.Phase 1 Terminated74 enrolled